Insider trades
John P. Hamill, CFO of Aprea Therapeutics APRE, has filed 5 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $10.9K. The latest trade was on 03/31.
John P. Hamill
SrVP/CFO/Prin Fin & Acct Ofcr
- Company
- Aprea Therapeutics APRE
- First filing
- 23/01/30
- Trades
- 20 trades
- Buys / sales
- 5 / 0
- 12-month net buying
- $10.9K
- Last trade
- 03/31
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy | 01/30 | 02/02 | 5,700 sh | $0.89 | $5,073 | +20.6% | |
| Open-market buy | 25/12/10 | 25/12/11 | 5,000 sh | $1.17 | $5,850 | +22.0% | |
| Open-market buy | 24/10/11 | 24/10/16 | 50 sh | $2.46 | $123 | +0.3% | |
| Open-market buy | 24/10/10 | 24/10/15 | 450 sh | $2.61 | $1,174.5 | +2.4% | |
| Open-market buy | 24/03/13 | 24/03/14 | 1,010 sh | $7.29 | $7,362.9 | +7.0% |